Cardiopulmonary Test

The Genuvi Cardiopulmonary Genetic Panel is a vital tool for identifying the genetic basis of complex cardiovascular and pulmonary diseases. With rapid results, broad genetic coverage, and clinically actionable reports, this test enables accurate diagnosis and proactive risk management for high-risk patients and their families.

Price

$799.00

USD

Would you like us to call you?

One of our agents will contact you

Introduction

Cardiopulmonary disorders are a major cause of morbidity and mortality worldwide, and many have an underlying genetic basis. The Genuvi Cardiopulmonary Genetic Panel is designed to detect pathogenic variants across a spectrum of genes associated with hereditary cardiac and pulmonary diseases.

Overview

[field_autop key="D1_Texto_1"]

Who Benefits from Cardiopulmonary Genetic Testing?

[field_autop key="D2_Texto_2"]

Panel Content and Functional Coverage

[field_autop key="D3_Texto_3"]

Technical Specifications

[field_autop key="D4_Texto_4"]

Test Methodology

[field_autop key="D5_Texto_5"]

Clinical Applications and Benefits

[field_autop key="D6_Texto_6"]

Genes Analyzed

[field_autop key="D7_Texto_7"]

Conclusion

[field_autop key="D8_Texto_8"]

Test Limitations

[field_autop key="D9_Texto_9"]

Regulatory Disclosures and References

[field_autop key="D10_Texto_10"]

Each panel is designed to detect single nucleotide variants (SNVs) and small insertions and deletions, with gene-specific limitations. The target regions include coding exons and the 10 bp intronic sequences immediately adjacent to each exon–intron boundary of every coding exon in these genes.